| Basics |
Bruker Corporation Common Stock
Bruker Corp is a developer, manufacturer and distributor of scientific instruments and analytical and dignostic solutions that enable customers to explore life and materials at microscopic, molecular and cellular levels.
|
| IPO Date: |
July 2, 2003 |
| Sector: |
Healthcare |
| Industry: |
Life Sciences Tools and Services |
| Market Cap: |
$5.91B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.41 | 1.66%
|
| Avg Daily Range (30 D): |
$1.07 | 2.71%
|
| Avg Daily Range (90 D): |
$1.11 | 2.27%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.61M |
| Avg Daily Volume (30 D): |
2.02M |
| Avg Daily Volume (90 D): |
1.59M |
| Trade Size |
| Avg Trade Size (Sh.): |
97 |
| Avg Trade Size (Sh.) (30 D): |
68 |
| Avg Trade Size (Sh.) (90 D): |
64 |
| Institutional Trades |
| Total Inst.Trades: |
8,747 |
| Avg Inst. Trade: |
$2.56M |
| Avg Inst. Trade (30 D): |
$4.17M |
| Avg Inst. Trade (90 D): |
$3.92M |
| Avg Inst. Trade Volume: |
.06M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$4.44M |
| Avg Closing Trade (30 D): |
$15.12M |
| Avg Closing Trade (90 D): |
$14.14M |
| Avg Closing Volume: |
90.27K |
|
|
|
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
$2.08
|
$.27
|
$.05
|
|
Diluted EPS
|
$2.07
|
$.27
|
$.05
|
|
Revenue
|
$ 3.24B
|
$ 864.4M
|
$ 800.7M
|
|
Gross Profit
|
$ 1.59B
|
$ 418.8M
|
$ 384.6M
|
|
Net Income / Loss
|
$ 304.5M
|
$ 40.3M
|
$ 7.6M
|
|
Operating Income / Loss
|
$ 284.5M
|
$ 68.1M
|
$ 48.1M
|
|
Cost of Revenue
|
$ 1.65B
|
$ 445.6M
|
$ 416.1M
|
|
Net Cash Flow
|
$ -215.2M
|
$ -21.5M
|
$ -170.1M
|
|
PE Ratio
|
18.70
|
|
|
|
